David Hall Discusses Six Month Results from Phase I/IIa Clinical Trial

Viral Networks Inc. recently interviewed David Hall, President and CEO of RepliCel. In the interview, he discusses the interim results from RepliCel’s first-in-man clinical trial. For the full video, please visit http://www.youtube.com/watch?v=9SjQAfiKAk0.

•